MedPath
NMPA Approval

Talquetamab Injection

国药准字SJ20250003

February 8, 2025

Drug Information

塔奎妥单抗注射液

拓立珂

注射剂

3mg(1.5ml)/瓶

生物制品

February 8, 2025

February 7, 2030

Company Information

Applicant Company

Turnhoutseweg 30, B-2340 Beerse, Belgium

Manufacturing Company

5900 Martin Luther King Jr. HWY, Greenville, NC 27834, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

塔奎妥单抗注射液 - NMPA 批准文号 | MedPath